Injective and Hedera Investors Pile into DeeStream, Seduced by the Bright Future of Streaming

Injective and Hedera Investors Pile into DeeStream, Seduced by the Bright Future of Streaming
Published on

Injective was one of 2024's early risers, peaking at all-time highs in March. Meanwhile, Hedera has been established and has around since 2021, hitting its all-time high during the last bull cycle. However, entering the next bull cycle, neither Injective nor Hedera will turn in the rare 100x; after all, both have already peaked. Instead, the REAL gains will be found in gems that haven't even BEGUN to peak yet. One of the top candidates to do just that is DeeStream. Injective and Hedera holders who took profit at the top are rotating their gains into DeeStream as it enters stage 2 of its presale—learn why.

Injective cools off in a big way

Injective was one of the undoubted stars of 2023, carrying on its meteoric run and peaking earlier in Q1 2024. However, entering the second quarter of 2024, Injective looks to have already peaked from its all-time highs of $52 set last March 14th, as Bitcoin hit a new all-time high. Since then, Injective has fallen by the wayside, crashing all the way to $22.63 exactly a month later last April 14th. Injective has recovered a bit, trading at $28 as of press time on April 23. Despite recording a 22.4% loss in the past 30 days, Injective remains up 300% in the past year.

Hedera banking on social volume

The significant mainstream attention brought on by increased social volume often propels projects to a price apex, leading to a subsequent pullback. Despite these considerations, it is noteworthy that Hedera remains one of the most profitable cryptocurrencies in the market for February. Notably, its value has surged by 50%, propelling Hedera to a 22-month high. Currently priced at $0.11, Hedera has experienced a 2.7% decrease in the last 24 hours.

DeeStream presale offering investors a potential 100x in the works

DeeStream is fast becoming the presale investment destination of the year, with Injective and Hedera holders diving headfirst into stage 2 of its presale. How? Unlike YouTube, Twitch, and TikTok, which suffer from a great deal of centralization and corporate meddling, DeeStream (DST) will allow content producers to generate and distribute high-quality video in the same way that conventional media does. In addition, the platform's native token DST will provide a plethora of opportunities for content producers to monetize their work without fear of censorship and predatory behavior from centralized platforms.

The second stage of the DeeStream presale has begun, and tokens may be purchased for the unbelievable price of just $0.066. Observers believe DeeStream is in line for larger returns than Injective and Hedera, which already sport billion-dollar market caps. DeeStream, on the other hand, hasn't even begun to scratch the surface of its vast potential to pump. Moreover, the income sharing model of DeeStream is another incentive that has proven to be a major draw in its presale.

Find out more about the DeeStream (DST) presale by visiting the website here.  

Join our WhatsApp Channel to get the latest news, exclusives and videos on WhatsApp

                                                                                                       _____________                                             

Disclaimer: Analytics Insight does not provide financial advice or guidance. Also note that the cryptocurrencies mentioned/listed on the website could potentially be scams, i.e. designed to induce you to invest financial resources that may be lost forever and not be recoverable once investments are made. You are responsible for conducting your own research (DYOR) before making any investments. Read more here.

Related Stories

No stories found.
logo
Analytics Insight
www.analyticsinsight.net